Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 2 Ovarian Neoplasms 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Nonhematologic Malignancies 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Somatostatinoma 1 Sarcoma, Synovial 1 Sarcoma 1 Recurrent Lung Squamous Cell Carcinoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Non-hematologic Malignancy 1 Neurofibrosarcoma 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 Meningeal Neoplasms 1 Lymphoma 1 Liver Neoplasms 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hematologic Neoplasms 1 Glioblastoma 1 Fibrolamellar hepatocellular carcinoma 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1

Interventions

Doxorubicin 33 Ifosfamide 23 Gemcitabine 19 pazopanib 18 Cyclophosphamide 16 Radiotherapy 15 pembrolizumab 13 Filgrastim 12 Docetaxel 12 Bevacizumab 10 Vincristine 9 Sirolimus 9 Irinotecan 9 Etoposide 9 olaratumab 7 eribulin 7 Sorafenib 7 Radiation 7 temsirolimus 6 Temozolomide 6 Mesna 6 Magnetic Resonance Spectroscopy 6 Cisplatin 6 tazemetostat 5 cixutumumab 5 Trabectedin 5 Radiosurgery 5 Nivolumab 5 Ipilimumab 5 Granulocyte Colony-Stimulating Factor 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Sarcoma × sapanisertib × Clear all

NCT02987959 2022-10-14

Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas

Fox Chase Cancer Center

Phase 2 Terminated

6 enrolled 10 charts

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡